Preoperative S-1 Plus Cisplatin-based Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma : Randomized, Phase II Trial
Latest Information Update: 30 Dec 2024
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
Most Recent Events
- 27 Dec 2024 Status changed from recruiting to completed.
- 21 Apr 2021 Planned End Date changed from 31 Jul 2021 to 31 Jul 2022.
- 21 Apr 2021 Planned primary completion date changed from 31 Dec 2020 to 31 Dec 2021.